ArticleLiver cancer2025

Immune Checkpoint Inhibitor plus Anti-VEGF/TKI Combined with Transarterial Chemoembolization in Locally Advanced Nonmetastatic Hepatocellular Carcinoma: Real-World Treatment Strategy Based on Phase 3 Clinical Trial Results.

Masatoshi KudoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.